Variable | Patients (N = 200) | Patients’ subgroups | ||
---|---|---|---|---|
Patients with positive tests (n = 11) | Patients with negative tests (n = 189) | p-value | ||
Hemoglobin level (Mean ± SD) | 12.65 ± 1.12 | 11.69 ± 1.42 | 12.71 ± 1.07 | 0.003* |
Cases with anemia (N. %) | 21 (10.5%) | 5 (45.5%) | 16 (8.5%) | 0.0001* |
HCT (Mean ± SD) | 39.11 ± 3.25 | 37.46 ± 4.7 | 39.2 ± 3.14 | 0.085 |
MCH (Mean ± SD) | 33.4 ± 4.57 | 30.52 ± 4.06 | 33.56 ± 4.55 | 0.031* |
MCV (Mean ± SD) | 78.62 ± 3.9 | 77.66 ± 3.17 | 78.68 ± 3.94 | 0.404 |
WBCs (Mean ± SD) | 6.27 ± 1.55 | 6.24 ± 1.65 | 6.27 ± 1.55 | 0.942 |
Platelets (Mean ± SD) | 297.34 ± 81.76 | 316.82 ± 125.47 | 296.21 ± 78.84 | 0.418 |
RBG (Mean ± SD) | 242.08 ± 74.18 | 282.91 ± 124.75 | 239.7 ± 69.95 | 0.060 |
Hb A1c (Mean ± SD) | 9.29 ± 1.64 | 10.74 ± 2.01 | 9.21 ± 1.58 | 0.002* |
Glycemic control (N. %) | ||||
Good control (HbA1c < 7.5%) Poor control (HbA1c ≥ 7.5%) | 68(34%) 132(66%) | 2(18.18%) 9(81.82%) | 66 (34.92%) 123(65.08%) | 0.255 |
tTG-IgA antibodies IU/ml | ||||
Median (IQ range) | 3.0 (1.85–4.3) | 230.6(48.7–260.2) | 2.8(1.7–4) | < 0.001* |
tTG-IgG antibodies IU/ml | ||||
Median (IQ range) | 4(2.9–5.7) | 38(15–59.7) | 3.8(2.65–5.3) | < 0.001* |